Drug Delivery

Next Expansion Milestone Achieved: SCHOTT Pharma Opens Production Facility in Serbia to Strengthen Competitiveness in Europe

After breaking ground in December 2023, SCHOTT Pharma today inaugurated a new manufacturing facility in central Serbia. The company's double-digit million euro investment is being realised with the start of the glass ampoule production, which will create around 180 jobs by the end of 2025.

Kindeva Drug Delivery acquires Summit Biosciences

Kindeva Drug Delivery, a provider of drug-device combination products, has announced the acquisition of Summit Biosciences, an intranasal drug-delivery contract development and manufacturing organisation (CDMO).

NovaBay to introduce new cream for psoriasis

NovaBay Pharmaceuticals has announced plans to launch a new cream specifically formulated for psoriasis.

Sofgen CDMO®

Sofgen CDMO is the global softgel CDMO — a Sofgen Pharma company with 50+ years of expertise in contract development and manufacturing.

Bavarian Nordic to supply smallpox and monkeypox vaccine to Switzerland

Bavarian Nordic has received an order from the Swiss Armed Forces and the Swiss Federal Office of Public Health for its Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox and monkeypox vaccine doses.

Bavarian Nordic and PAHO sign agreement for monkeypox vaccines

Bavarian Nordic has signed a supply agreement with the Pan American Health Organization (PAHO) for its monkeypox vaccine.

Eli Lilly launches citrate-free Taltz formulation

Eli Lilly and Company has announced that its Taltz (ixekizumab) 80mg/mL injection is now available in a new, citrate-free formulation.

Bavarian Nordic to supply additional monkeypox vaccine doses to US

Bavarian Nordic has received an order from the US Biomedical Advanced Research and Development Authority (BARDA) for additional doses of Jynneos, a non-replicating vaccine against smallpox and monkeypox.

US buys additional Bavarian Nordic’s smallpox and monkeypox vaccine doses

The US Biomedical Advanced Research and Development Authority (BARDA) has ordered additional doses of Bavarian Nordic’s Jynneos, a non-replicating vaccine to prevent smallpox and monkeypox.